Case Studies

Aureon is applying Systems Pathology to develop predictive and prognostic models in order to facilitate biologically relevant decisions which can be made earlier in the drug development process that are objective, quantifiable, reproducible and reliable; enabling clinical trials that are shorter, smaller, smarter, and less costly.

Aureon has conducted pilot projects in both prostate and lung cancer that have resulted in case studies for your review.